Modulation of alpha interferon anti-hepatitis C virus activity by ISG15

Journal of General Virology

Volumn 90, Issue 12, 2009, Pages 2929-2939

  Chua, Pong Kian ^a   McCown, Matthew F ^a   Rajyaguru, Sonal ^a   Kular, Simran ^a   Varma, Ram ^a   Symons, Julian ^a   Chiu, Sophie S ^a   Cammack, Nick ^a   Nájera, Isabel ^a  

^a ROCHE BIOSCIENCE   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

2',5' OLIGOADENYLATE SYNTHETASE; ALPHA INTERFERON; ALPHA2A INTERFERON; GAMMA INTERFERON; HEPATITIS C ANTIBODY; INTERFERON REGULATORY FACTOR; INTERFERON REGULATORY FACTOR 15; PROTEIN IFI6; PROTEIN IFITM3; PROTEIN MX1; SMALL INTERFERING RNA; UBIQUITIN; UBIQUITIN SPECIFIC PROTEASE 18; UNCLASSIFIED DRUG; VIRUS PROTEIN; VIRUS RNA;

ANTIVIRAL ACTIVITY; ARTICLE; CONTROLLED STUDY; GENE EXPRESSION; GENE EXPRESSION REGULATION; GENOTYPE; HELA CELL; HEPATITIS C VIRUS; HUMAN; HUMAN CELL; KNOCKOUT GENE; PHENOTYPE; PRIORITY JOURNAL; PROTEIN FUNCTION; REPLICON; VIRUS REPLICATION;

CELL LINE; CELL LINE, TUMOR; CYTOKINES; GENE EXPRESSION REGULATION; HELA CELLS; HEPACIVIRUS; HEPATOCYTES; HUMANS; INTERFERON ALFA-2A; INTERFERON-ALPHA; RNA, SMALL INTERFERING; TRANSFECTION; UBIQUITINS; VIRUS REPLICATION;

HEPATITIS C VIRUS;

EID: 70849106860     PISSN: 00221317     EISSN: 14652099     Source Type: Journal    
DOI: 10.1099/vir.0.013128-0     Document Type: Article

References (43)

1. Asahina, Y., Izumi, N., Hirayama, I., Tanaka, T., Sato, M., Yasui, Y., Komatsu, N., Umeda, N., Hosokawa, T. & other authors (2008). Potential relevance of cytoplasmic viral sensors and related regulators involving innate immunity in antiviral response. Gastroenterology 134, 1396-1405.
2. Asselah, T., Bieche, I., Narguet, S., Sabbagh, A., Laurendeau, I., Ripault, M. P., Boyer, N., Martinot-Peignoux, M., Valla, D. & other authors (2008). Liver gene expression signature to predict response to pegylated interferon plus ribavirin combination therapy in patients with chronic hepatitis C. Gut 57, 516-524.
3. Brem, R., Oraszlan-Szovik, K., Foser, S., Bohrmann, B. & Certa, U. (2003). Inhibition of proliferation by 1-8U in interferon-α-responsive and non-responsive cell lines. Cell Mol Life Sci 60, 1235-1248.
4. Chen, L., Borozan, I., Feld, J., Sun, J., Tannis, L. L., Coltescu, C., Heathcote, J., Edwards, A. M. & McGilvray, I. D. (2005). Hepatic gene expression discriminates responders and nonresponders in treatment of chronic hepatitis C viral infection. Gastroenterology 128, 1437-1444.
5. Cheney, I. W., Lai, V. C., Zhong, W., Brodhag, T., Dempsey, S., Lim, C., Hong, Z., Lau, J. Y. & Tam, R. C. (2002). Comparative analysis of antihepatitis C virus activity and gene expression mediated by alpha, beta, and gamma interferons. J Virol 76, 11148-11154.
6. D'Cunha, J., Knight, E., Jr, Haas, A. L., Truitt, R. L. & Borden, E. C. (1996a). Immunoregulatory properties of ISG15, an interferon-induced cytokine. Proc Natl Acad Sci U S A 93, 211-215.
7. D'Cunha, J., Ramanujam, S., Wagner, R. J., Witt, P. L., Knight, E., Jr & Borden, E. C. (1996b). In vitro and in vivo secretion of human ISG15, an IFN-induced immunomodulatory cytokine. J Immunol 157, 4100-4108.
8. Frese, M., Schwarzle, V., Barth, K., Krieger, N., Lohmann, V., Mihm, S., Haller, O. & Bartenschlager, R. (2002). Interferon-γ inhibits replication of subgenomic and genomic hepatitis C virus RNAs. Hepatology 35, 694-703.
9. Gale, M. & Foy, E. M. (2005). Evasion of intracellular host defence by hepatitis C virus. Nature 436, 939-945.
10. Gee, P., Chua, P. K., Gevorkyan, J., Klumpp, K., Najera, I., Swinney, D. C. & Deval, J. (2008). Essential role of the N-terminal domain in the regulation of RIG-I ATPase activity. J Biol Chem 283, 9488-9496.
11. Guerra, S., Caceres, A., Knobeloch, K. P., Horak, I. & Esteban, M. (2008). Vaccinia virus E3 protein prevents the antiviral action of ISG15. PLoS Pathog 4, e1000096.
12. Haas, A. L., Ahrens, P., Bright, P. M. & Ankel, H. (1987). Interferon induces a 15-kilodalton protein exhibiting marked homology to ubiquitin. J Biol Chem 262, 11315-11323.
13. Hsiang, T. Y., Zhao, C. & Krug, R. M. (2009). Interferon-induced ISG15 conjugation inhibits influenza A virus gene expression and replication in human cells. J Virol 83, 5971-5977.
14. Itsui, Y., Sakamoto, N., Kurosaki, M., Kanazawa, N., Tanabe, Y., Koyama, T., Takeda, Y., Nakagawa, M., Kakinuma, S. & other authors (2006). Expressional screening of interferon-stimulated genes for antiviral activity against hepatitis C virus replication. J Viral Hepat 13, 690-700.
15. Jiang, D., Guo, H., Xu, C., Chang, J., Gu, B., Wang, L., Block, T. M. & Guo, J. T. (2008). Identification of three interferon-inducible cellular enzymes that inhibit the replication of hepatitis C virus. J Virol 82, 1665-1678.
16. Kim, K. I., Yan, M., Malakhova, O., Luo, J. K., Shen, M. F., Zou, W., de la Torre, J. C. & Zhang, D. E. (2006). Ube1L and protein ISGylation are not essential for alpha/beta interferon signaling. Mol Cell Biol 26, 472-479.
17. Kim, M. J., Hwang, S. Y., Imaizumi, T. & Yoo, J. Y. (2008). Negative feedback regulation of RIG-I-mediated antiviral signaling by interferon-induced ISG15 conjugation. J Virol 82, 1474-1483.
18. Klumpp, K., Leveque, V., Le Pogam, S., Ma, H., Jiang, W. R., Kang, H., Granycome, C., Singer, M., Laxton, C. & other authors (2006). The novel nucleoside analog R1479 (4′-azidocytidine) is a potent inhibitor of NS5B-dependent RNA synthesis and hepatitis C virus replication in cell culture. J Biol Chem 281, 3793-3799.
19. Lenschow, D. J., Giannakopoulos, N. V., Gunn, L. J., Johnston, C., O'Guin, A. K., Schmidt, R. E., Levine, B. & Virgin, H. W., IV (2005). Identification of interferon-stimulated gene 15 as an antiviral molecule during Sindbis virus infection in vivo. J Virol 79, 13974-13983.
20. Lenschow, D. J., Lai, C., Frias-Staheli, N., Giannakopoulos, N. V., Lutz, A., Wolff, T., Osiak, A., Levine, B., Schmidt & other authors (2007). IFN-stimulated gene 15 functions as a critical antiviral molecule against influenza, herpes, and Sindbis viruses. Proc Natl Acad Sci U S A 104, 1371-1376.
21. Liu, M., Li, X. L. & Hassel, B. A. (2003). Proteasomes modulate conjugation to the ubiquitin-like protein, ISG15. J Biol Chem 278, 1594-1602.
22. Malakhov, M. P., Malakhova, O. A., Kim, K. I., Ritchie, K. J. & Zhang, D. E. (2002). UBP43 (USP18) specifically removes ISG15 from conjugated proteins. J Biol Chem 277, 9976-9981.
23. Malakhov, M. P., Kim, K. I., Malakhova, O. A., Jacobs, B. S., Borden, E. C. & Zhang, D. E. (2003). High-throughput immunoblotting. Ubiquitiin-like protein ISG15 modifies key regulators of signal transduction. J Biol Chem 278, 16608-16613.
24. Malakhova, O. A. & Zhang, D. E. (2008). ISG15 inhibits Nedd4 ubiquitin E3 activity and enhances the innate antiviral response. J Biol Chem 283, 8783-8787.
25. Manns, M. P., Foster, G. R., Rockstroh, J. K., Zeuzem, S., Zoulim, F. & Houghton, M. (2007). The way forward in HCV treatment - finding the right path. Nat Rev Drug Discov 6, 991-1000.
26. Manthey, C. L., Wang, S. W., Kinney, S. D. & Yao, Z. (1998). SB202190, a selective inhibitor of p38 mitogen-activated protein kinase, is a powerful regulator of LPS-induced mRNAs in monocytes. J Leukoc Biol 64, 409-417.
27. Okumura, A., Lu, G., Pitha-Rowe, I. & Pitha, P. M. (2006). Innate antiviral response targets HIV-1 release by the induction of ubiquitin-like protein ISG15. Proc Natl Acad Sci U S A 103, 1440-1445.
28. Okumura, A., Pitha, P. M. & Harty, R. N. (2008). ISG15 inhibits Ebola VP40 VLP budding in an L-domain-dependent manner by blocking Nedd4 ligase activity. Proc Natl Acad Sci U S A 105, 3974-3979.
29. Osiak, A., Utermohlen, O., Niendorf, S., Horak, I. & Knobeloch, K. P. (2005). ISG15, an interferon-stimulated ubiquitin-like protein, is not essential for STAT1 signaling and responses against vesicular stomatitis and lymphocytic choriomeningitis virus. Mol Cell Biol 25, 6338-6345.
30. Randall, R. E. & Goodbourn, S. (2008). Interferons and viruses: an interplay between induction, signalling, antiviral responses and virus countermeasures. J Gen Virol 89, 1-47.
31. Randall, G., Chen, L., Panis, M., Fischer, A. K., Lindenbach, B. D., Sun, J., Heathcote, J., Rice, C. M., Edwards, A. M. & McGilvray, I. D. (2006). Silencing of USP18 potentiates the antiviral activity of interferon against hepatitis C virus infection. Gastroenterology 131, 1584-1591.
32. Randall, G., Panis, M., Cooper, J. D., Tellinghuisen, T. L., Sukhodolets, K. E., Pfeffer, S., Landthaler, M., Landgraf, P., Kan, S. & other authors (2007). Cellular cofactors affecting hepatitis C virus infection and replication. Proc Natl Acad Sci U S A 104, 12884-12889.
33. Recht, M., Borden, E. C. & Knight, E., Jr (1991). A human 15-kDa IFN-induced protein induces the secretion of IFN-gamma. J Immunol 147, 2617-2623.
34. Sarasin-Filipowicz, M., Oakeley, E. J., Duong, F. H., Christen, V., Terracciano, L., Filipowicz, W. & Heim, M. H. (2008). Interferon signaling and treatment outcome in chronic hepatitis C. Proc Natl Acad Sci U S A 105, 7034-7039.
35. Takeuchi, T., Kobayashi, T., Tamura, S. & Yokosawa, H. (2006). Negative regulation of protein phosphatase 2Cβ by ISG15 conjugation. FEBS Lett 580, 4521-4526.
36. Wong, J. J., Pung, Y. F., Sze, N. S. & Chin, K. C. (2006). HERC5 is an IFN-induced HECT-type E3 protein ligase that mediates type I IFN-induced ISGylation of protein targets. Proc Natl Acad Sci U S A 103, 10735-10740.
37. Yi, M., Villanueva, R. A., Thomas, D. L., Wakita, T. & Lemon, S. M. (2006). Production of infectious genotype 1a hepatitis C virus (Hutchinson strain) in cultured human hepatoma cells. Proc Natl Acad Sci U S A 103, 2310-2315.
38. Yuan, W. & Krug, R. M. (2001). Influenza B virus NS1 protein inhibits conjugation of the interferon (IFN)-induced ubiquitin-like ISG15 protein. EMBO J 20, 362-371.
39. Zhang, Y., Burke, C. W., Ryman, K. D. & Klimstra, W. B. (2007). Identification and characterization of interferon-induced proteins that inhibit alphavirus replication. J Virol 81, 11246-11255.
40. Zhao, C., Beaudenon, S. L., Kelley, M. L., Waddell, M. B., Yuan, W., Schulman, B. A., Huibregtse, J. M. & Krug, R. M. (2004). The UbcH8 ubiquitin E2 enzyme is also the E2 enzyme for ISG15, an IFN-α/ β-induced ubiquitin-like protein. Proc Natl Acad Sci U S A 101, 7578-7582.
41. Zhao, C., Denison, C., Huibregtse, J. M., Gygi, S. & Krug, R. M. (2005). Human ISG15 conjugation targets both IFN-induced and constitutively expressed proteins functioning in diverse cellular pathways. Proc Natl Acad Sci U S A 102, 10200-10205.
42. Zhu, H. & Liu, C. (2003). Interleukin-1 inhibits hepatitis C virus subgenomic RNA replication by activation of extracellular regulated kinase pathway. J Virol 77, 5493-5498.
43. Zhu, H., Zhao, H., Collins, C. D., Eckenrode, S. E., Run, Q., McIndoe, R. A., Crawford, J. M., Nelson, D. R., She, J. X. & Liu, C. (2003). Gene expression associated with interferon alfa antiviral activity in an HCV replicon cell line. Hepatology 37, 1180-1188.